Calcium involvement in luteinizing hormone-releasing hormone release from the bovine infundibulum.
Bovine infundibular (stalk median eminence) explants were incubated in vitro to test the hypothesis that calcium (Ca) is involved in the release of luteinizing hormone-releasing hormone (LHRH) from LHRH neuron terminals in cattle. Right and left infundibular halves from individual heifers and/or steers were randomly assigned to either control or treated (EGTA [a Ca chelator] or verapamil [an L-type Ca channel antagonist]) groups. Each half was incubated in 600 microliters of Krebs-Ringer bicarbonate medium (KRB) in the presence or absence of a treatment agent for 180 min. At 30-min intervals, 500-microliters samples were removed from each incubated and replaced with fresh media. Spontaneous (basal) and depolarization-induced (60 mM potassium) LHRH release was evaluated by radioimmunoassay of the LHRH content in the media incubated from 91 to 120 and 121 to 150 min of culture, respectively. The effect of treatment on depolarization-induced LHRH release was analyzed by comparing the differences between spontaneous and depolarization-induced LHRH release in control and treated groups. Spontaneous LHRH release was not different between control and 1.25 mM EGTA- or 100 microM verapamil-treated halves from steers. In contrast, steer infundibular halves incubated with EGTA (replacing Ca in KRB and chelating any Ca in the media) released less LHRH during depolarization than did control halves. In addition, verapamil-treated (to block Ca uptake by the terminal) infundibular halves from steers or heifers released less LHRH in response to depolarization than did control halves.(ABSTRACT TRUNCATED AT 250 WORDS)
Dippel
W W
WW
Department of Animal Science, Texas A&M University, College Station 77843, USA.
Chen
P L
PL
McArthur
N H
NH
Harms
P G
PG
D000818:Animals; D001639:Bicarbonates / Q000494:pharmacology; D002118:Calcium / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002417:Cattle / Q000378:metabolism*; D002614:Chelating Agents / Q000494:pharmacology; D046508:Culture Techniques; D004533:Egtazic Acid / Q000494:pharmacology; D005089:Exocytosis / Q000502:physiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D008297:Male; D008473:Median Eminence / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D011897:Random Allocation; D014700:Verapamil / Q000494:pharmacology
D001639:Bicarbonates; D002121:Calcium Channel Blockers; D002614:Chelating Agents; D007987:Gonadotropin-Releasing Hormone; D004533:Egtazic Acid; D014700:Verapamil; D002118:Calcium